- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07718581 | HMPL-A830 in Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 147 | HutchmedINDUSTRY | 1 | Jul 22, 2026 | clinicaltrials |
| NCT07487805 | Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)(ICONIC) | not yet recruiting | Phase 2 | 80 | University of FloridaOTHER | 0 | Jul 15, 2026 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 22, 2026source: clinicaltrials